RxPreferred flips the script on rising healthcare costs with Mark Cuban Cost Plus Drug Company
RxPreferred News Subscribe RxPreferred flips the script on rising healthcare costs with Mark Cuban Cost Plus Drug Company, offering Humira® Biosimilar, YUSIMRY™, to plans and members. RxPreferred’s inclusion of YUSIMRY™ will have a significant impact on employersponsored health plans and their members with the biosimilar representing a 92% discount from the list price for Humira®. The blockbuster move will improve access to medication for patients that previously could not afford
Mark Cuban Cost Plus Drug Company and RxPreferred benefits annouce partnership
RxPreferred Benefits, a transparent Pharmacy Benefit Administrator, and Mark Cuban
Cost Plus Drugs, PBC (Cost Plus Drugs), have announced a new partnership today, focused on improving healthcare access and
lowering drug spend.
County Saves Money By Switching To RxPreferred
In the search for more affordable healthcare, one county found by switching the pharmacy benefits management to RxPreferred could save them as much as $75K annually.
RxPreferred: Helping Independent Pharmacies Serve the Underserved
Independent pharmacies are unique and so is RxPreferred’s approach to PBM and 340B Administration. Founded and solely owned by independent pharmacy representatives, they know first-hand how hard it is to be on the other side of the counter.
Interview with CEO Jeff Malone – Honest Apothecary
Jason Poquette and The Honest Apothecary sat down with President and CEO of RxPreferred Benefits, Jeff Malone, to talk about all things pharmacy benefits management.
Pharmacy Podcast – A Conversation with RxPreferred’s Jeff Malone
RxPreferred Benefits’ President and CEO, Jeff Malone, joined Pharmacy Podcast host, Todd Eury to discuss PBM, 340B, and how RxPreferred is changing how organizations view PBM.